Gilde Healthcare III secures Philips commitment

The venture fund has a €200m target and is expected to hold a first close towards the end of the year.

Philips' commitment is part of the company's strategy to drive innovation in healthcare. Consequently, Gilde Healthcare III will focus on early- and growth-stage healthcare technology companies in Europe and the US that are active in developing and commercialising new patient-centric healthcare solutions, medical technologies and therapeutics, with particular emphasis on cardiology, oncology and women's health.

The predecessor fund, Gilde Healthcare II, launched in February 2006 and held a final close in October 2007 on its €150m hard-cap.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Venture
• DACH
• France
• Nordics
• Southern Europe
• UK / Ireland
• Benelux
• Fundraising
• Healthcare
• Gilde Investment Management
• Netherlands